21Shares has launched the 21Shares Injective Staking ETP (AINJ) on Euronext Paris and Amsterdam, providing investors with exposure to the Injective Protocol while capturing staking yields. This new addition is part of 21Shares' growing lineup of physically-backed crypto ETPs. The Injective Staking ETP tracks the performance of INJ and reinvests staking yields to enhance performance. This product offers a regulated and transparent way to benefit from Injective's capabilities in decentralized finance (DeFi), supporting seamless interactions across major networks and enabling various financial products and services.
Disclaimer: Please note that the information provided in this article is based on the referenced research articles. It is essential to conduct further research and analysis before making any investment decisions. The cryptocurrency market is highly volatile, and investors should exercise caution and consult with financial professionals before engaging in cryptocurrency trading or investment activities.
